Literature DB >> 11846741

Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families.

O Oszurek, B Gorski, J Gronwald, Z Prosolow, K Uglanica, A Murinow, I Bobko, O Downar, M Zlobicz, D Norik, T Byrski, A Jakubowska, J Lubinski.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11846741     DOI： 10.1034/j.1399-0004.2001.600611.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  12 in total

1.  High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.

Authors:  Laima Tikhomirova; Olga Sinicka; Dagnija Smite; Janis Eglitis; Shirley V Hodgson; Aivars Stengrevics
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.

Authors:  Lucian Negura; Nancy Uhrhammer; Anca Negura; Vlad Artenie; Eugen Carasevici; Yves-Jean Bignon
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  BRCA1 4153delA founder mutation in Russian ovarian cancer patients.

Authors:  Nadezhda Yu Krylova; Oksana S Lobeiko; Anna P Sokolenko; Aglaya G Iyevleva; Maxim E Rozanov; Natalia V Mitiushkina; Madina M Gergova; Tatiana V Porhanova; Adel F Urmancheyeva; Sergey Ya Maximov; Alexandr V Togo; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2006-09-15       Impact factor: 2.857

4.  Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer.

Authors:  Pavel Elsakov; Juozas Kurtinaitis; Valerij Ostapenko
Journal:  Fam Cancer       Date:  2007-05-23       Impact factor: 2.375

5.  Coverage of the genetic background of breast cancer in the polish population.

Authors:  Pablo Serrano-Fernández; Bohdan Górski; Tadeusz Debniak; Cezary Cybulski; Tomasz Byrski; Tomasz Huzarski; Jacek Gronwald; Anna Jakubowska; Oleg Oszurek; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2006-11-15       Impact factor: 2.857

6.  Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.

Authors:  Anna P Sokolenko; Maxim E Rozanov; Natalia V Mitiushkina; Natalia Yu Sherina; Aglaya G Iyevleva; Elena V Chekmariova; Konstantin G Buslov; Evgeny S Shilov; Alexandr V Togo; Elena M Bit-Sava; Dmitry A Voskresenskiy; Oleg L Chagunava; Peter Devilee; Cees Cornelisse; Vladimir F Semiglazov; Evgeny N Imyanitov
Journal:  Fam Cancer       Date:  2007-02-28       Impact factor: 2.446

7.  Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland.

Authors:  Tomasz Kluz; Andrzej Jasiewicz; Elżbieta Marczyk; Robert Jach; Anna Jakubowska; Jan Lubiński; Steven A Narod; Jacek Gronwald
Journal:  Hered Cancer Clin Pract       Date:  2018-02-27       Impact factor: 2.857

8.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

9.  High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.

Authors:  Evgeny N Suspitsin; Nathalia Yu Sherina; Daria N Ponomariova; Anna P Sokolenko; Aglaya G Iyevleva; Tatyana V Gorodnova; Olga A Zaitseva; Olga S Yatsuk; Alexandr V Togo; Nathalia N Tkachenko; Grigory A Shiyanov; Oksana S Lobeiko; Nadezhda Yu Krylova; Dmitry E Matsko; Sergey Ya Maximov; Adel F Urmancheyeva; Nathalia V Porhanova; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2009-02-25       Impact factor: 2.857

10.  BRCA1 founder mutations compared to ovarian cancer in Belarus.

Authors:  Alena Savanevich; Oleg Oszurek; Jan Lubiński; Cezary Cybulski; Tadeusz Dębniak; Steven A Narod; Jacek Gronwald
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.